Skip to main content

Table 1 Study and patient population characteristics

From: Troponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart review

 

AED1

AED2

CED

Total

Total ED visits Jan 01 2008 - Dec 31 2008

75,500

57,300

63,000

195,800

Total visits with AF as 1° or 2° Dx

473

271

404

1,148

Patient characteristics (%)

    
 

N = 150

N = 151

N = 150

N = 451

Age

    

< 50

29 (19.3)

22 (14.6)

18 (12.0)

69 (15.3)

51-60

27 (18)

30 (19.9)

16 (10.7)

73 (16.2)

61-74

27 (18.0)

39 (25.8)

45 (30.0)

111 (24.6)

≥ 75

67 (44.7)

60 (39.7)

71 (47.3)

198 (43.9)

Gender

    

Male

89 (59.3)

98 (64.9)

72 (48.0)

259 (57.4)

Female

61 (40.7)

53 (35.1)

78 (52.0)

192 (42.6)

Type of AF

    

New onset

51 (34.0)

51 (33.8)

36 (24.2)

138 (30.7)

Paroxysmal

92 (61.3)

93 (61.6)

94 (63.1)

279 (62.0)

Persistent

7 (4.7)

6 (4.0)

9 (6.0)

22 (4.9)

Unknown

0 (0)

1 (0.7)

10 (6.7)

11 (2.4)

Duration of symptoms

    

< 48 h

91 (60.7)

93 (61.6)

100 (67.1)

284 (63.1)

48 h

56 (37.3)

51 (33.8)

33 (22.2)

140 (31.1)

Unknown

3 (2.0)

7 (4.6)

16 (10.7)

26 (5.8)

Past medical history

    

History of CHF or EF < 35%

40 (26.7)

30 (19.9)

10 (6.7)

80 (17.9)

HTN

91 (60.7)

80 (53.0)

98 (65.8)

269 (59.8)

CAD

49 (32.7)

31 (20.5)

43 (28.9)

123 (27.3)

DM

20 (13.3)

19 (12.7)

30 (20.1)

69 (15.4)

Previous stroke/TIA

21 (14.0)

23 (15.2)

28 (18.8)

72 (16.0)

Prosthetic heart valve

11 (7.3)

7 (4.6)

5 (3.4)

23 (5.1)

CHADS2 Score*

    

0

41 (23.7)

45 (29.8)

29 (19.3)

115 (25.5)

1

25 (16.7)

43 (28.5)

40 (26.7)

108 (23.9)

2

34 (22.7)

34 (22.5)

39 (26.0)

107 (23.7)

≥ 3

50 (33.3)

29 (19.2)

42 (28.0)

121 (26.8)

  1. *1 point each for congestive heart failure, hypertension, age > 75 years, diabetes, and 2 points for transient ischemic attack or stroke